Overview

Myopia Control: a Comparison Study Between Atropine and MiSight

Status:
Not yet recruiting
Trial end date:
2026-03-13
Target enrollment:
Participant gender:
Summary
This research project aims to provide additional knowledge of pharmacological and optical methods of myopia control and to gain a better understanding of the biometry of the pediatric eye, which contributes to the onset and progression of myopia. As a result, this study will improving our best practices for myopia control in pediatric patients.
Phase:
Phase 2
Details
Lead Sponsor:
Ann & Robert H Lurie Children's Hospital of Chicago
Treatments:
Atropine